{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T04:29:51Z","timestamp":1727238591613},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,24]]},"DOI":"10.7759\/cureus.70098","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T14:33:24Z","timestamp":1727188404000},"source":"Crossref","is-referenced-by-count":0,"title":["Severe Cutaneous Reaction Induced by Clindamycin: A Case Report of Toxic Epidermal Necrolysis"],"prefix":"10.7759","author":[{"given":"Gabriel","family":"Scally","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohannes","family":"Haile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen","family":"Seylani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas W","family":"Sheets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-39","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"5","author":"Harr T","year":"2010","unstructured":"Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis. 2010, 5:39. 10.1186\/1750-1172-5-39","journal-title":"Orphanet J Rare Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57090895","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of diagnosis and management","volume":"57","author":"Frantz R","year":"2021","unstructured":"Frantz R, Huang S, Are A, Motaparthi K. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of diagnosis and management. Medicina (Kaunas). 2021, 57:1-15. 10.3390\/medicina57090895","journal-title":"Medicina (Kaunas)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-40812-3","article-title":"Correlations between histopathologic findings, serum biomarker levels, and clinical outcomes in Stevens-Johnson syndrome\/toxic epidermal necrolysis (SJS\/TEN)","volume":"13","author":"Chuenwipasakul D","year":"2023","unstructured":"Chuenwipasakul D, Washrawirul C, Panpruk R, et al.. Correlations between histopathologic findings, serum biomarker levels, and clinical outcomes in Stevens-Johnson syndrome\/toxic epidermal necrolysis (SJS\/TEN). Sci Rep. 2023, 13:13620. 10.1038\/s41598-023-40812-3","journal-title":"Sci Rep"},{"key":"ref4","unstructured":"Clindamycin. (2023). Accessed. 2\/11\/2024: https:\/\/www.statpearls.com\/point-of-care\/19602."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.12.015","article-title":"Antibiotic drug use and the risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: a population-based case-control study","volume":"138","author":"Frey N","year":"2018","unstructured":"Frey N, Bircher A, Bodmer M, Jick SS, Meier CR, Spoendlin J. Antibiotic drug use and the risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: a population-based case-control study. J Invest Dermatol. 2018, 138:1207-9. 10.1016\/j.jid.2017.12.015","journal-title":"J Invest Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omaa020","article-title":"Clindamycin induced toxic epidermal necrolysis versus Staphylococcal scalded skin syndrome: a case report","volume":"2020","author":"Davey MG","year":"2020","unstructured":"Davey MG, Birrane J, Brennan M, Breen DP, Laing ME. Clindamycin induced toxic epidermal necrolysis versus Staphylococcal scalded skin syndrome: a case report. Oxf Med Case Reports. 2020, 2020:omaa020. 10.1093\/omcr\/omaa020","journal-title":"Oxf Med Case Reports"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb08730.x","article-title":"Toxic epidermal necrolysis following clindamycin treatment","volume":"132","author":"Paquet P","year":"1995","unstructured":"Paquet P, Schaaf-Lafontaine N, Pi\u00e9rard GE. Toxic epidermal necrolysis following clindamycin treatment. Br J Dermatol. 1995, 132:665-6. 10.1111\/j.1365-2133.1995.tb08730.x","journal-title":"Br J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/ijstd.IJSTD_61_19","article-title":"Study of genital manifestations of Stevens Johnson syndrome\/toxic epidermal necrolysis","volume":"43","author":"Gulanikar A","year":"2022","unstructured":"Gulanikar A, Abrol A, Sagar S. Study of genital manifestations of Stevens Johnson syndrome\/toxic epidermal necrolysis. Indian J Sex Transm Dis AIDS. 2022, 43:39-42. 10.4103\/ijstd.IJSTD_61_19","journal-title":"Indian J Sex Transm Dis AIDS"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin S","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993, 129:92-6.","journal-title":"Arch Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.3654","article-title":"Assessment and comparison of performance of ABCD-10 and SCORTEN in prognostication of epidermal necrolysis","volume":"156","author":"Koh HK","year":"2020","unstructured":"Koh HK, Fook-Chong S, Lee HY. Assessment and comparison of performance of ABCD-10 and SCORTEN in prognostication of epidermal necrolysis. JAMA Dermatol. 2020, 156:1294-9. 10.1001\/jamadermatol.2020.3654","journal-title":"JAMA Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700068","article-title":"Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis","volume":"126","author":"Gu\u00e9gan S","year":"2006","unstructured":"Gu\u00e9gan S, Bastuji-Garin S, Poszepczynska-Guign\u00e9 E, Roujeau JC, Revuz J. Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis. J Invest Dermatol. 2006, 126:272-6. 10.1038\/sj.jid.5700068","journal-title":"J Invest Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.8027","article-title":"Recurrent toxic epidermal necrolysis with two different drugs in a patient with chronic kidney disease-a case report with an atypical presentation","volume":"11","author":"Mathur M","year":"2023","unstructured":"Mathur M, Thakur N, Jaiswal S, Maharjan S, Paudel S, Shrestha A. Recurrent toxic epidermal necrolysis with two different drugs in a patient with chronic kidney disease-a case report with an atypical presentation. Clin Case Rep. 2023, 11:e8027. 10.1002\/ccr3.8027","journal-title":"Clin Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.939210","article-title":"Chronic kidney disease is potentially an independent prognostic factor for death in Stevens-Johnson syndrome and toxic epidermal necrolysis patients","volume":"9","author":"Rattanakaemakorn P","year":"2022","unstructured":"Rattanakaemakorn P, Palakornkitti P, Pinyowiwat P, Jedee P, Thadanipon K. Chronic kidney disease is potentially an independent prognostic factor for death in Stevens-Johnson syndrome and toxic epidermal necrolysis patients. Front Med (Lausanne). 2022, 9:939210. 10.3389\/fmed.2022.939210","journal-title":"Front Med (Lausanne)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64284-8","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand","volume":"162","author":"Abe R","year":"2003","unstructured":"Abe R, Shimizu T, Shibaki A, Nakamura H, Watanabe H, Shimizu H. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. Am J Pathol. 2003, 162:1515-20. 10.1016\/S0002-9440(10)64284-8","journal-title":"Am J Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung WH","year":"2008","unstructured":"Chung WH, Hung SI, Yang JY, et al.. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med. 2008, 14:1343-50. 10.1038\/nm.1884","journal-title":"Nat Med"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1093\/milmed\/167.8.701","article-title":"A case report and a proposed algorithm for the transfer of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis to a burn center","volume":"167","author":"Ellis MW","year":"2002","unstructured":"Ellis MW, Oster CN, Turiansky GW, Blanchard JR. A case report and a proposed algorithm for the transfer of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis to a burn center. Mil Med. 2002, 167:701-4.","journal-title":"Mil Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/all.15608","article-title":"Intravenous immunoglobulins, cyclosporine, and best supportive care in epidermal necrolysis: diverse effects on systemic inflammation","volume":"78","author":"Schmidt V","year":"2023","unstructured":"Schmidt V, Lalev\u00e9e S, Traidl S, et al.. Intravenous immunoglobulins, cyclosporine, and best supportive care in epidermal necrolysis: diverse effects on systemic inflammation. Allergy. 2023, 78:1280-91. 10.1111\/all.15608","journal-title":"Allergy"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.08.051","article-title":"Medical management of Stevens-Johnson syndrome\/toxic epidermal necrolysis among North American dermatologists","volume":"87","author":"Han JJ","year":"2022","unstructured":"Han JJ, Creadore A, Seminario-Vidal L, Micheletti R, Noe MH, Mostaghimi A. Medical management of Stevens-Johnson syndrome\/toxic epidermal necrolysis among North American dermatologists. J Am Acad Dermatol. 2022, 87:429-31. 10.1016\/j.jaad.2021.08.051","journal-title":"J Am Acad Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2007.06.008","article-title":"Toxic epidermal necrolysis: use of Biobrane or skin coverage reduces pain, improves mobilisation and decreases infection in elderly patients","volume":"34","author":"Boorboor P","year":"2008","unstructured":"Boorboor P, Vogt PM, Bechara FG, Alkandari Q, Aust M, Gohritz A, Spies M. Toxic epidermal necrolysis: use of Biobrane or skin coverage reduces pain, improves mobilisation and decreases infection in elderly patients. Burns. 2008, 34:487-92. 10.1016\/j.burns.2007.06.008","journal-title":"Burns"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdin.2023.06.014","article-title":"Epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States and factors predictive of outcome","volume":"13","author":"Wasuwanich P","year":"2023","unstructured":"Wasuwanich P, So JM, Chakrala TS, Chen J, Motaparthi K. Epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States and factors predictive of outcome. JAAD Int. 2023, 13:17-25. 10.1016\/j.jdin.2023.06.014","journal-title":"JAAD Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/233773-severe-cutaneous-reaction-induced-by-clindamycin-a-case-report-of-toxic-epidermal-necrolysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T14:33:28Z","timestamp":1727188408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/233773-severe-cutaneous-reaction-induced-by-clindamycin-a-case-report-of-toxic-epidermal-necrolysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,24]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.70098","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,24]]}}}